A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects

NCT02365948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

BIOLOGICAL: Certolizumab Pegol
OTHER: Placebo

Sponsor

UCB Pharma SA

Collaborators

[object Object]